Shiyang Pan
Overview
Explore the profile of Shiyang Pan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu Y, Zhu L, Li S, Liu L, Wang Y, Yang Y, et al.
Cell Rep
. 2025 Mar;
44(3):115364.
PMID: 40023842
Neuronal signals have emerged as pivotal regulators of B cells that regulate antitumor immunity and tumor progression. However, the functional relevance and mechanistic basis of the effects of the neurotransmitter...
2.
Zhang L, Zhou Y, Yang S, Zhu Q, Xu J, Mu Y, et al.
Clin Chem Lab Med
. 2025 Feb;
PMID: 39891359
Objectives: Although existing cytopathological examination is considered essential for the diagnosis of malignant serous effusions, its accuracy is pretty low. Tumor specific protein 70 (SP70), which is highly expressed on...
3.
CBC With Differential and Cell Population Data in Prediction of Fever With Thrombocytopenia Syndrome
Zhang L, Yang S, Cheng C, Mu Y, Pan S
Int J Lab Hematol
. 2024 Dec;
47(2):221-227.
PMID: 39692012
Introduction: We aimed to identify additional predictors of severe fever with thrombocytopenia syndrome (SFTS), which has a significantly increasing global incidence. Methods: This retrospective study included 95 patients with SFTS...
4.
Gu Y, Chu C, Yuan B, Wang J, Pan S
Histol Histopathol
. 2024 Jan;
39(8):1043-1051.
PMID: 38213260
This study aimed to explore the expression and hypermethylation of EPB41L3 and JAM3 in cervical squamous cell carcinoma (CSCC) and to investigate their clinical significance. JAM3 and EPB41L3 mRNA expression...
5.
Xu H, Chen C, Chen L, Pan S
J Cell Mol Med
. 2023 Dec;
28(3):e18084.
PMID: 38130025
IRF family genes have been shown to be crucial in tumorigenesis and tumour immunity. However, information about the role of IRF in the systematic assessment of pan-cancer and in predicting...
6.
Wu L, Xia W, Hua Y, Fan K, Lu Y, Wang M, et al.
Front Pharmacol
. 2023 Dec;
14:1295442.
PMID: 38044943
Non-small cell lung cancer (NSCLC) exhibits heterogeneity with diverse immune cell infiltration patterns that can influence tumor cell behavior and immunotherapy. A comprehensive characterization of the tumor microenvironment can guide...
7.
Gu M, Jin Y, Gao X, Xia W, Xu T, Pan S
Front Immunol
. 2023 Nov;
14:1278521.
PMID: 37928545
Interleukin-37 (IL-37) is a newly discovered member of IL-1 family. The cytokine was proved to have extensive protective effects in infectious diseases, allergic diseases, metabolic diseases, autoimmune diseases and tumors...
8.
Lu Y, Xia W, Miao S, Wang M, Wu L, Xu T, et al.
Infect Drug Resist
. 2023 Oct;
16:6735-6745.
PMID: 37873032
Objective: This study aimed to investigate the clinical characteristics and risk factors of death in severe coronavirus disease 2019 (COVID-19) during the epidemic of Omicron variants, assess the clinical value...
9.
Chen W, Hua Y, Shan C, Wei J, Zhou Y, Pan S
Front Oncol
. 2023 Jun;
13:1182301.
PMID: 37384302
Background: Treatment with programmed cell death protein-1 (PD-1) antibodies has minimal response rates in patients with non-small cell lung cancer (NSCLC), and, actually, they are treated with chemotherapy combined with...
10.
Results from an IFCC global survey on laboratory practices for the analysis of circulating tumor DNA
Linder M, Huggett J, Baluchova K, Capoluongo E, Payne D, Salinas A, et al.
Clin Chim Acta
. 2023 May;
547:117398.
PMID: 37217114
Background: The clinical validity of ctDNA analysis as a diagnostic, prognostic and predictive biomarker has been demonstrated in many studies. The rapid spread of tests for the analysis of ctDNA...